(original) (raw)
Cases in Lymphoma™ Webinar Series
Treatment of CLL: Evolving Options for BTK Inhibitors
This webinar discusses the evolving options for BTK inhibitors in Chronic Lymphocytic Leukemia (CLL) based on a transcript of a medical discussion. The conversation revolves around two patient cases and provides insights into the treatment decision-making process.
Treatment of Chronic Lymphocytic Leukemia: Therapeutic Challenges
This educational video provides a comprehensive overview of the current landscape in CLL treatment, highlighting the challenges and advances in therapy, especially in the context of the COVID-19 pandemic. The presenters, all experts in the field of hematology and oncology, offer valuable insights into patient management, evolving treatments, and the importance of MRD in guiding therapy decisions.
ASTCT CAR-T SERIES WEBINARS
CAR-T Basics & Biology
The first in ASTCT’s new CAR-T Webinar Series aired on June 9, 2021 with our speaker, Dr. Marcela Maus, and our moderator, Dr. Armin Ghobadi. This webinar, ‘CAR-T Basics and Biology’ covered an overall review of CAR-T Biology, the general process of generating CAR-T, CAR-T targets, the future directions of CAR-T biology, and more!
Clinical Advances in CAR T-Cell Therapy
The second in ASTCT’s CAR-T Webinar Series aired on June 29, 2021 at 2 PM CT with speaker, Dr. Frederick Locke, and our moderator, Dr. Akshay Sharma. This webinar, ‘Clinical Advances in CAR T-Cell Therapy’ covered a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more!
CAR-T vs. Transplant: Complements or Competitors?
The third installment of the CAR T Webinar Series from ASTCT. This webinar will feature a presentation by Dr. Scott Goldsmith, highlighting the key areas of CAR T vs. Transplant, including consultation, day-to-day management, sequential therapy, and the pros and cons of each.
CAR-T Toxicity Management and Grading
The fourth installment of the CAR T Webinar Series from ASTCT. This webinar will feature a presentation by Dr. Martina Pennisi, highlighting the key areas of CAR T toxicity management, including CRS/ICANS grading and management, as well as late post-infusion care.
TOPICS IN HEMATOLOGY
Browse Bloodline Webinars & Resources